BRPI0921860A2 - compostos de benzonaftiridina como inibidores de autotaxina - Google Patents
compostos de benzonaftiridina como inibidores de autotaxinaInfo
- Publication number
- BRPI0921860A2 BRPI0921860A2 BRPI0921860A BRPI0921860A BRPI0921860A2 BR PI0921860 A2 BRPI0921860 A2 BR PI0921860A2 BR PI0921860 A BRPI0921860 A BR PI0921860A BR PI0921860 A BRPI0921860 A BR PI0921860A BR PI0921860 A2 BRPI0921860 A2 BR PI0921860A2
- Authority
- BR
- Brazil
- Prior art keywords
- autotaxin inhibitors
- benzonaphthyridine compounds
- benzonaphthyridine
- compounds
- autotaxin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008059578A DE102008059578A1 (de) | 2008-11-28 | 2008-11-28 | Benzo-Naphtyridin Verbindungen |
PCT/EP2009/007930 WO2010060532A1 (de) | 2008-11-28 | 2009-11-05 | Benzo-naphtyridin verbindungen als inhibitoren von autotaxin |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0921860A2 true BRPI0921860A2 (pt) | 2015-12-29 |
Family
ID=42107404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0921860A BRPI0921860A2 (pt) | 2008-11-28 | 2009-11-05 | compostos de benzonaftiridina como inibidores de autotaxina |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110230471A1 (pt) |
EP (1) | EP2352733A1 (pt) |
JP (1) | JP2012509916A (pt) |
KR (1) | KR20110095392A (pt) |
CN (1) | CN102227426A (pt) |
AR (1) | AR074418A1 (pt) |
AU (1) | AU2009319421A1 (pt) |
BR (1) | BRPI0921860A2 (pt) |
CA (1) | CA2744833A1 (pt) |
DE (1) | DE102008059578A1 (pt) |
EA (1) | EA201100880A1 (pt) |
IL (1) | IL213052A0 (pt) |
MX (1) | MX2011005531A (pt) |
WO (1) | WO2010060532A1 (pt) |
ZA (1) | ZA201104749B (pt) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201106817D0 (en) | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compound |
WO2013054185A1 (en) * | 2011-10-13 | 2013-04-18 | Pfizer, Inc. | Pyrimidine and pyridine derivatives useful in therapy |
WO2013070879A1 (en) | 2011-11-10 | 2013-05-16 | Bristol-Myers Squibb Company | Methods for treating spinal cord injury with lpa receptor antagonists |
NZ702334A (en) | 2012-06-13 | 2016-11-25 | Hoffmann La Roche | New diazaspirocycloalkane and azaspirocycloalkane |
DK2900669T3 (da) | 2012-09-25 | 2019-11-04 | Hoffmann La Roche | Hexahydropyrrolo[3,4-C]pyrrolderivater og relaterede forbindelser som autotaxin (ATX)-inhibitorer og som inhibitorer af lysophosphatidsyre (LPA)-produktion til behandling af f.eks. nyresygdomme |
WO2014048313A1 (zh) * | 2012-09-27 | 2014-04-03 | 烟台大学 | 茶氨酸衍生物与羧酸香豆素衍生物的缩合产物及其中间体、其制备方法和用途 |
US20140171404A1 (en) | 2012-12-19 | 2014-06-19 | Novartis Ag | Autotaxin inhibitors |
US9409895B2 (en) | 2012-12-19 | 2016-08-09 | Novartis Ag | Autotaxin inhibitors |
JPWO2014133112A1 (ja) * | 2013-03-01 | 2017-02-02 | 国立大学法人 東京大学 | オートタキシン阻害活性を有する8−置換イミダゾピリミジノン誘導体 |
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
MX358342B (es) | 2013-03-14 | 2018-08-15 | Galapagos Nv | Compuestos y composiciones farmaceuticas de los mismos para el tratamiento de trastornos inflamatorios. |
EP3046909A4 (en) | 2013-09-17 | 2017-03-29 | Pharmakea, Inc. | Heterocyclic vinyl autotaxin inhibitor compounds |
JP2016530209A (ja) | 2013-09-17 | 2016-09-29 | ファーマケア,インク. | ビニルオートタキシン阻害剤化合物 |
WO2015048301A1 (en) | 2013-09-26 | 2015-04-02 | Pharmakea, Inc. | Autotaxin inhibitor compounds |
SI3071561T1 (sl) | 2013-11-22 | 2021-11-30 | Sabre Therapeutics Llc | Spojine, ki inhibirajo avtotaksin |
CN105764903B (zh) | 2013-11-22 | 2018-09-18 | 法玛克亚公司 | 四环自分泌运动因子抑制剂 |
WO2015078803A1 (en) | 2013-11-26 | 2015-06-04 | F. Hoffmann-La Roche Ag | NEW OCTAHYDRO-CYCLOBUTA [1,2-c;3,4-c']DIPYRROL-2-YL |
MX2016008131A (es) | 2013-12-20 | 2016-09-16 | Astex Therapeutics Ltd | Compuestos heterociclos biciclicos y sus usos en terapia. |
AU2015238537B2 (en) | 2014-03-26 | 2019-08-01 | F. Hoffmann-La Roche Ag | Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors |
JP6554481B2 (ja) | 2014-03-26 | 2019-07-31 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | オートタキシン(atx)及びリゾホスファチジン酸(lpa)産生の阻害剤としての縮合[1,4]ジアゼピン化合物 |
US9051320B1 (en) | 2014-08-18 | 2015-06-09 | Pharmakea, Inc. | Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor |
GB201501870D0 (en) | 2015-02-04 | 2015-03-18 | Cancer Rec Tech Ltd | Autotaxin inhibitors |
GB201502020D0 (en) | 2015-02-06 | 2015-03-25 | Cancer Rec Tech Ltd | Autotaxin inhibitory compounds |
MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
IL280863B1 (en) | 2015-05-27 | 2024-03-01 | Sabre Therapeutics Llc | Ototaxin inhibitors and their uses |
RU2746481C1 (ru) | 2015-09-04 | 2021-04-14 | Ф. Хоффманн-Ля Рош Аг | Феноксиметильные производные |
KR20180054634A (ko) | 2015-09-24 | 2018-05-24 | 에프. 호프만-라 로슈 아게 | 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 신규한 이환형 화합물 |
RU2725138C2 (ru) | 2015-09-24 | 2020-06-30 | Ф. Хоффманн-Ля Рош Аг | Новые бициклические соединения в качестве двойных ингибиторов аутотаксина (atx)/карбоангидразы (ca) |
MX2018002217A (es) | 2015-09-24 | 2018-03-23 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores de autotaxina (atx). |
RU2018112230A (ru) | 2015-09-24 | 2019-10-30 | Ф. Хоффманн-Ля Рош Аг | Бициклические соединения в качестве ингибиторов atx |
WO2018167001A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | Heterocyclic compounds useful as dual atx/ca inhibitors |
JP7090099B2 (ja) | 2017-03-16 | 2022-06-23 | エフ.ホフマン-ラ ロシュ アーゲー | Atxインヒビターとしての新規二環式化合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3889302T2 (de) * | 1987-12-03 | 1994-10-20 | Mitsubishi Chem Ind | 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff. |
US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
US6294547B1 (en) * | 1997-06-30 | 2001-09-25 | Nippon Kayaku Kabushiki Kaisha | Naphthyridine deratives or salts thereof |
GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
AU4972900A (en) | 1999-04-08 | 2000-11-14 | Arch Development Corporation | Use of anti-vegf antibody to enhance radiation in cancer therapy |
-
2008
- 2008-11-28 DE DE102008059578A patent/DE102008059578A1/de not_active Withdrawn
-
2009
- 2009-11-05 CN CN2009801476046A patent/CN102227426A/zh active Pending
- 2009-11-05 CA CA2744833A patent/CA2744833A1/en not_active Abandoned
- 2009-11-05 AU AU2009319421A patent/AU2009319421A1/en not_active Abandoned
- 2009-11-05 US US13/131,696 patent/US20110230471A1/en not_active Abandoned
- 2009-11-05 KR KR1020117014790A patent/KR20110095392A/ko not_active Application Discontinuation
- 2009-11-05 MX MX2011005531A patent/MX2011005531A/es unknown
- 2009-11-05 WO PCT/EP2009/007930 patent/WO2010060532A1/de active Application Filing
- 2009-11-05 EA EA201100880A patent/EA201100880A1/ru unknown
- 2009-11-05 EP EP09751814A patent/EP2352733A1/de not_active Withdrawn
- 2009-11-05 JP JP2011537865A patent/JP2012509916A/ja active Pending
- 2009-11-05 BR BRPI0921860A patent/BRPI0921860A2/pt not_active Application Discontinuation
- 2009-11-27 AR ARP090104585A patent/AR074418A1/es unknown
-
2011
- 2011-05-22 IL IL213052A patent/IL213052A0/en unknown
- 2011-06-27 ZA ZA2011/04749A patent/ZA201104749B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201104749B (en) | 2012-03-28 |
AR074418A1 (es) | 2011-01-19 |
US20110230471A1 (en) | 2011-09-22 |
IL213052A0 (en) | 2011-07-31 |
CN102227426A (zh) | 2011-10-26 |
DE102008059578A1 (de) | 2010-06-10 |
CA2744833A1 (en) | 2010-06-03 |
AU2009319421A1 (en) | 2011-07-14 |
EA201100880A1 (ru) | 2012-01-30 |
WO2010060532A1 (de) | 2010-06-03 |
KR20110095392A (ko) | 2011-08-24 |
JP2012509916A (ja) | 2012-04-26 |
MX2011005531A (es) | 2011-06-21 |
EP2352733A1 (de) | 2011-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0921860A2 (pt) | compostos de benzonaftiridina como inibidores de autotaxina | |
BR112012000792A2 (pt) | compostos heterocíclicos como inibidores de autotaxina | |
BRPI1009800A2 (pt) | compostos heterocíclicos como inibidores de autotaxina | |
DK2376490T3 (da) | Imidazopyridinforbindelser | |
BRPI0916375A2 (pt) | compostos orgânicos como inibidores de smo | |
BRPI0913879A2 (pt) | fenilpirazinonas como inibidores de quinase | |
BRPI0920135A2 (pt) | imidazopiridazinacarbonitrilos úteis como inibidores de quinase | |
BRPI1013614A2 (pt) | compostos substituídos de espiro-amida | |
BRPI0922845A2 (pt) | pirazol-4-n-alcoxicarboxamidas como microbiocidas | |
BRPI0913580A2 (pt) | pirrolopiridinas como inibidores de quinase | |
DOP2012000045A (es) | Compuestos químicos | |
BR112013015449A2 (pt) | compostos de bi-heteroarila como inibidores de vps23 | |
BRPI1014708A2 (pt) | dihidropirimidinonas para uso como inibidores de bace2 | |
BR112012006859A2 (pt) | compostos | |
DK2427449T3 (da) | Vinylindazolylforbindelser | |
DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
BRPI0920707A2 (pt) | compostos | |
BRPI1005525A2 (pt) | compostos de azaazuleno | |
SMT201600045B (it) | Composti tetraciclinici c7-fluoro sostituiti | |
DK3345903T3 (da) | Tetracykliske forbindelser | |
DK2242759T3 (da) | Forbindelser | |
BRPI0912475A2 (pt) | compostos como inibidores de quinase | |
DK2297162T3 (da) | Forbindelser | |
BRPI0925050A2 (pt) | Compostos heterocíclicos como inibidores de mek | |
BR112012003868A2 (pt) | Compostos orgânicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |